Clinical study on ultrasound-guided intra-articular injection of compound betamethasone for the treatment of degenerative knee osteoarthritis
Discussion of Clinical Cases · 20.04.2026 · 11 (3) · 12-16
DOI: 10.5430/dcc.v11n3p12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discussion of Clinical Cases, online erschienen am 20.04.2026. Verfasst von Daxing Guo und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To explore the clinical efficacy of ultrasound-guided intra-articular injection of compound betamethasone for degenerative knee osteoarthritis.
Methods
A total of 78 patients diagnosed with degenerative knee osteoarthritis at a tertiary A-grade hospital between February 2020 and February 2022 were randomly divided to the injection therapy group and the non-injection therapy group, with 39 patients in each group. The injection therapy group received the ultrasound-guided intra-articular injections of compound betamethasone, while the non-injection therapy group underwent conventional acupuncture treatment. The therapeutic effects, pain levels, osteoarthritis indices, and quality of life between the two groups were compared to evaluate the efficacy of ultrasoundguided intra-articular injection of compound betamethasone for treating degenerative knee osteoarthritis.
Results
The total response rate in the injection therapy group was higher than that in the non-injection therapy group (94.87% vs. 74.36%, p = .012). Comparison of Visual Analogue Scale (VAS) scores between the two groups: the pre-treatment VAS scores were 2.34 ± 0.43 in the injection therapy group and 2.37 ± 0.32 in the non-injection therapy group (p = .727), showing no statistically significant difference. The post-treatment VAS scores were lower in the injection therapy group than in the non-injection therapy group (1.04 ± 0.21 vs. 1.76 ± 0.34, p < .001), indicating a statistically significant difference. Comparison of knee osteoarthritis index (WOMAC) scores between the two groups: the pre-treatment WOMAC scores were 49.88 ± 2.12 in the injection therapy group and 49.76 ± 2.43 in the non-injection therapy group (p = .816), showing no statistically significant difference. The post-treatment WOMAC scores were lower in the injection therapy group than that in the non-injection therapy group (22.34 ± 2.32 vs. 34.54 ± 2.36, p < .001), indicating a statistically significant difference. The two groups were assessed by use of the SF-36 health survey questionnaire to compare differences in physical functioning, bodily pain, mental health, social functioning, and overall health. The pre-treatment differences were not statistically significant (p > .05). While in the post-treatment, the injection therapy group demonstrated significantly higher SF-36 scores across all domains in comparison to the non-injection therapy group (p < .001).
Conclusions
Patients with degenerative knee osteoarthritis who undergo ultrasound-guided intra-articular injection of compound betamethasone demonstrate improved therapeutic outcomes, reduced pain levels, enhanced joint function, and elevated quality of life.
Zitieren
APA
Guo, D., & Li, P. (2026). Clinical study on ultrasound-guided intra-articular injection of compound betamethasone for the treatment of degenerative knee osteoarthritis. Discussion of Clinical Cases, 11(3), 12-16. https://doi.org/10.5430/dcc.v11n3p12
Vancouver
Guo D, Li P. Clinical study on ultrasound-guided intra-articular injection of compound betamethasone for the treatment of degenerative knee osteoarthritis. Discussion of Clinical Cases. 2026;11(3):12-16. doi:10.5430/dcc.v11n3p12
BibTeX
@article{Guo2026,
author = {Guo, Daxing and Li, Ping},
title = {Clinical study on ultrasound-guided intra-articular injection of compound betamethasone for the treatment of degenerative knee osteoarthritis},
journal = {Discussion of Clinical Cases},
year = {2026},
volume = {11},
number = {3},
pages = {12--16},
doi = {10.5430/dcc.v11n3p12}
}
EUVIMED